ArticleHeliyon2024
IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy.
Chunmei Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleHeliyon2024
Chunmei Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.